Srikanth Reddy, MD
Srikanth Reddy, MD
Physician, Epic Care
Castro Valley, CA
Physician, Epic Care
San Leandro, CA
"Practicing medical oncology and hematology is more than a career - to me it is a calling. My mission is to work tirelessly in helping my patients. To that end, I continually strive to improve my medical knowledge and skills to provide leadership and guidance for all in my care. I also strive to stay grounded, take time to understand my patients, and establish with them the close partnership that is vital to good care." Dr Reddy practices Hematology and Medical Oncology at Epic Care's Castro Valley and San Leandro Care Centers. He also has affiliations with/privileges at Eden Medical Center, Castro Valley Campus, Castro Valley, CA; Eden Medical Center, San Leandro Campus, San Leandro, CA; St Rose Hospital, Hayward, CA; and Stanford Health Care, ValleyCare Medical Center, Pleasanton, CA.
Dr Reddy was born in Brooklyn, New York, and grew up in India. He graduated with a Bachelor of Science in Chemistry at the University of California, Berkeley, and obtained his Doctor of Medicine degree from Albany Medical College in Albany, New York. Dr Reddy completed an internship, residency, and fellowship at the University of California, Irvine. During his tenure, he received departmental awards for both service and promoting the education mission of UCI Medical Center. He then served as a hospitalist at Mission Hospital in Mission Viejo, California, for one year before joining Epic Care.
Dr Reddy is a member of The American Society of Clinical Oncology (ASCO),
The Alameda-Contra Costa Medical Association (ACCMA), The Association of Northern California Oncologists (ANCO), and the American Society of Hematology
(ASH). His areas of special interest include lymphomas and benign hematology.
Amit Singh Tibb, MD, FCCP
Amit Singh Tibb, MD, FCCP
Chief Quality Officer, Valley Medical Group
Director of Palliative Medicine, The Valley Hospital
Ridgewood, NJ
Clinical Assistant Professor of Medicine
Albert Einstein College of Medicine
Bronx, NY
Dr Tibb currently serves as Chief Quality Officer of the Valley Medical Group, in addition to being the Medical Director of Palliative Care at The Valley Hospital. Dr Tibb is Board certified in Internal Medicine, Pulmonary Diseases, Critical Care, Neurocritical Care and Palliative & Hospice Medicine. He retains faculty position as Clinical Assistant Professor of Medicine at Albert Einstein College of Medicine.
Dr Tibb graduated from Lokmanya Tilak Municipal Medical College, at the University of Mumbai, and completed his residency and fellowship at Albert Einstein College of Medicine, Bronx, New York. In addition, Dr Tibb completed a fellowship in Medical Simulation and held faculty position at the Institute of Medical Simulation and Learning (IMSAL). He also completed a fellowship in Clinical Quality and Patient Safety. and his work has been recognized both locally and nationally with several awards for Quality Improvement.
In 2012-13 and 2013-14, Dr Tibb received the 'GAGE' award from America's essential hospitals for "Palliative Care Integration in the ICU" & "CAUTI reduction – Journey towards ZERO" respectively. At Valley Medical Group, Dr Tibb is involved with Population Health and is instrumental in using Quality Metrics to drive physician compensation. Dr Tibb has served as faculty for numerous medical societies, including several Critical Care Ultrasound courses over the last 7 years, and has given grand rounds on integration of Ultrasound in the Intensive Care Unit, both nationally and internationally. His work in Quality Improvement has been recognized nationally with several awards and Dr Tibb has several peer-reviewed publications. His exemplary work as an educator has been recognized in the form of "Best Educator" award for 3 consecutive years from 2011-2014. Dr Tibb is a standing Fellow of the American College of Chest Physicians.
1. | Identify key steps necessary in initiating and implementing a QI project | 2. | Identify interventions that can improve the quality of care related to irAEs |
3. | Recognize clinical and process issues related to the use of immuno-oncology agents, and specifically irAEs | 4. | Analyze practice data to assess improvements in quality measures |
1. | Identify key steps necessary in initiating and implementing a QI project |
2. | Identify interventions that can improve the quality of care related to irAEs |
3. | Recognize clinical and process issues related to the use of immuno-oncology agents, and specifically irAEs |
4. | Analyze practice data to assess improvements in quality measures |